A better way to control where drugs go? Investors bet on small biotech’s mission to ‘click’ together cancer meds

While José Mejía Oneto was an orthopedic surgery resident at UC Davis, he learned an intriguing yet frustrating fact: Only small amounts of a drug — in some cases just 1% or 2% of what’s administered — actually make it to the target location.

That concerning fact left Mejía Oneto...

Click to view original post